COVID-19 has been affecting the world unprecedentedly and will remain widely prevalent due to its elusive pathophysiological mechanism and the continuous emergence of new variants. Critically ill ...

(“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris trial, a Phase 3 ...

In this procedure, blood is removed from the patient and circulated through an extracorporeal circuit, which purifies the blood before it is returned to the patient. Hemoperfusion (HP) is a type of ...

ExThera Medical is currently developing the ONCObind Procedure Hemoperfusion Filter (ONCObind) to support cancer treatment. ONCObind is part of the same platform technology as Seraph 100.

ExThera Medical has been awarded funding by the Medical Technology Enterprise Consortium (MTEC) to perform a randomized controlled trial to evaluate the efficacy of the Seraph ® 100 Microbind ® ...

Sepsis, a life-threatening and intractable disease without any specific treatment, is activated by endotoxin. Some attempts at removing endotoxin to treat sepsis from the blood circulation using ...